EOSINOPHILIC ASTHMA
Clinical trials for EOSINOPHILIC ASTHMA explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC ASTHMA trials appear
Sign up with your email to follow new studies for EOSINOPHILIC ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended safety check for promising severe asthma treatment
Disease control TerminatedThis study aimed to check the long-term safety of an experimental drug called dexpramipexole for adults with severe eosinophilic asthma. It enrolled 509 participants who had already completed one of two earlier Phase 3 trials. The main goal was to monitor for side effects and cha…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 01:41 UTC
-
New pill aims to tame severe asthma attacks
Disease control TerminatedThis study tested whether an oral medication called dexpramipexole could help control severe asthma in people with a specific type called eosinophilic asthma. Over 1,000 participants aged 12 and up, whose asthma was not well-controlled despite standard medications, took either th…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New pill aims to tame severe asthma Flare-Ups
Disease control TerminatedThis study tested an oral medication called dexpramipexole for people with a specific, hard-to-treat type of severe asthma. It aimed to see if taking the pill for a year could reduce the number of serious asthma attacks and improve lung function and quality of life. The trial inv…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC